01302 LIFETECH SCI

Comments on the semiannual report of Xianjian Technology (01302.HK) in 2021: the performance exceeded expectations and steadily implemented the "internationalization + platform" innovation and R & D strategy.

09-24-2021 00:00:00

First Health Technology (01302.HK): rapid volume products of left atrial appendage have been approved one after another.

09-23-2021 00:00:00

Comments of Xianjian Technology (01302.HK) Co., Ltd.: semi-annual report results grow rapidly and adhere to the strategy of innovation and international development.

09-20-2021 00:00:00

Xianjian Technology (01302.HK): great increase in performance in the first half of the year, strong technological strength and long-term improvement.

07-23-2021 00:00:00

Comments on the 2020 Annual report of Xianjian Technology (01302.HK): the performance is in line with the expected pipeline to enter the harvest period.

04-14-2021 00:00:00

Xianjian Technology (01302.HK): innovative equipment Dark Horse intervention Pearl of consumables

11-30-2020 00:00:00

Guoxin Securities: the DRGs pilot project is further expanded to grasp the three main lines of pharmaceutical investment

10-21-2020 15:41:00

Comments on the announcement of Xianjian Technology (01302.HK): the future growth of small and beautiful innovative devices is promising.

04-09-2020 00:00:00

First Health Technology (01302.HK): three business segments support performance growth products all over the world

04-01-2020 00:00:00

Pioneer Technology (01302.HK): innovation leads the development of products into a comprehensive harvest period

04-08-2019 00:00:00